In these cases, the use of protocols including GnRH antagonists and regimens with low-dose gonadotropin were recommended to reduce the ovarian response and minimise the occurrence and/or severity of ovarian hyperstimulation syndrome[53]. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.